retatrutide weight loss clinical results Results: 24% in 48 Weeks Retatrutide for weight loss: Study
Description
Understanding the mechanisms, risk factors, and safety considerations helps patients distinguish normal adaptation from concerning symptoms
Retatrutide's main side effects in trials: nausea (43%), heart rate increase of ~6.7 bpm, and dysesthesia (20.9%) at the 12 mg dose
Novo Nordisk and Ascendis Pharma have partnered to develop a long-acting, monthly GLP-1 drug
If you're not on a GLP-1, there are better-targeted options for general nutritional support
A mismatch between the outer box and pen device may indicate counterfeit production
